Menopausal Hormone Therapy Reduces Risk of Low Bone Mineral Density by 69%, Retrospective Study Finds

Menopausal hormone therapy reduces risk of low bone mineral density by 69%, retrospective study finds

Women on menopausal hormone therapy face a decreased risk of low bone mineral density compared with those not using it, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.

Menopause: Hormone therapy linked to 69% lower risk of thinning bones

Researchers found that women taking menopausal hormone therapy had a 69% lower risk of low bone mineral density than those not using hormone replacement, helping to prevent bone fractures.

Menopausal hormone therapy linked to stronger bone health

Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Hormone therapy use may protect against low bone mineral density in postmenopausal women

CHICAGO — In postmenopausal women, use of menopausal hormone therapy was associated with higher bone mineral density compared with nonuse, according to a study presented at ENDO 2026. “We undertook this study because menopausal hormone therapy (MHT) remains one of the most effective interventions for preserving bone mass after menopause, yet many eligible women continue to avoid treatment,” Diego

Menopausal Hormone Therapy Could Help Maintain Bone Strength, Study Finds

A growing body of research shows that menopausal hormone therapy can do more than help women manage bothersome symptoms like hot flashes and night sweats. A new study finds that it can be a major tool in preventing osteoporosis , a disease where the bones lose density, becoming more brittle and fragile.e60dc2a1-f33c-4a05-9b50-8e3e8e5976295beb94e9-fe6c-4d5d-8749-7862d38d9242 The research found that women taking hormone therapy were nearly 70 perc…

Worried About Menopausal Bone Loss? Study Shows This Provides Protection

A new study found menopausal hormone therapy is associated with 69% lower odds of low bone mineral density—reframing MHT as more than a symptom-relief tool.